These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26841833)

  • 1. A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis.
    Kim Y; Yi H; Jung H; Rim YA; Park N; Kim J; Jung SM; Park SH; Park YW; Ju JH
    Sci Rep; 2016 Feb; 6():20150. PubMed ID: 26841833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anacardic acid suppresses fibroblast-like synoviocyte proliferation and invasion and ameliorates collagen-induced arthritis in a mouse model.
    Yang GH; Zhang C; Wang N; Meng Y; Wang YS
    Cytokine; 2018 Nov; 111():350-356. PubMed ID: 30273785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel fusion protein attenuates collagen-induced arthritis by targeting interleukin 17A and tumor necrosis factor α.
    Liu Z; Song L; Wang Y; Xu P; Guo X; Yang J; Liu H; Wang Y; Wu C; Zhang T; Yu D; Opoku YK; Khoso MH; Ren G; Li D
    Int J Pharm; 2018 Aug; 547(1-2):72-82. PubMed ID: 29803792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
    Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
    Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
    Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
    Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.
    Yoo SA; Yoon HJ; Kim HS; Chae CB; De Falco S; Cho CS; Kim WU
    Arthritis Rheum; 2009 Feb; 60(2):345-54. PubMed ID: 19180491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
    Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of novel bispecific antibody targeting TNF-α/CXCL10 in the treatment of experimental arthritis.
    Kang SE; Park JK; Yoo HJ; Kang HS; Park YW; Park BC; Park JE; Lee EY; Lee EB; Song YW
    Transl Res; 2021 Jun; 232():75-87. PubMed ID: 33453429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.
    McCann FE; Perocheau DP; Ruspi G; Blazek K; Davies ML; Feldmann M; Dean JL; Stoop AA; Williams RO
    Arthritis Rheumatol; 2014 Oct; 66(10):2728-38. PubMed ID: 24965881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
    Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
    Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWEAK promotes osteoclastogenesis in rheumatoid arthritis.
    Park JS; Kwok SK; Lim MA; Oh HJ; Kim EK; Jhun JY; Ju JH; Park KS; Park YW; Park SH; Kim HY; Cho YG; Cho ML
    Am J Pathol; 2013 Sep; 183(3):857-67. PubMed ID: 23845567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itaconate reduces proliferation and migration of fibroblast-like synoviocytes and ameliorates arthritis models.
    Tada M; Kudo Y; Kono M; Kanda M; Takeyama S; Sakiyama K; Ishizu H; Shimizu T; Endo T; Hisada R; Fujieda Y; Kato M; Amengual O; Iwasaki N; Atsumi T
    Clin Immunol; 2024 Jul; 264():110255. PubMed ID: 38763433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
    Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
    Fischer JA; Hueber AJ; Wilson S; Galm M; Baum W; Kitson C; Auer J; Lorenz SH; Moelleken J; Bader M; Tissot AC; Tan SL; Seeber S; Schett G
    Arthritis Rheumatol; 2015 Jan; 67(1):51-62. PubMed ID: 25303306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
    Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
    Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperlongumine attenuates collagen-induced arthritis via expansion of myeloid-derived suppressor cells and inhibition of the activation of fibroblast-like synoviocytes.
    Sun J; Xu P; Du X; Zhang Q; Zhu Y
    Mol Med Rep; 2015 Apr; 11(4):2689-94. PubMed ID: 25435301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of apoptosis and inflammatory responses by insulin-like growth factor binding protein 3 in fibroblast-like synoviocytes and experimental animal models of rheumatoid arthritis.
    Lee HS; Woo SJ; Koh HW; Ka SO; Zhou L; Jang KY; Lim HS; Kim HO; Lee SI; Park BH
    Arthritis Rheumatol; 2014 Apr; 66(4):863-73. PubMed ID: 24757139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis.
    Liu X; Zhou H; Huang X; Cui J; Long T; Xu Y; Liu H; Yu R; Zhao R; Luo G; Huang A; Liang JG; Liang P
    J Immunol; 2016 Oct; 197(8):3029-3037. PubMed ID: 27619991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.